Goodwill of ANI PHARMACEUTICALS INC from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
ANI PHARMACEUTICALS INC quarterly Goodwill in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • ANI PHARMACEUTICALS INC Goodwill for the quarter ending 30 Sep 2025 was $62,480,000, a 3.4% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

ANI PHARMACEUTICALS INC Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $62,480,000 +$2,054,000 +3.4% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $60,533,000 +$32,312,000 +114% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $60,662,000 +$32,441,000 +115% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $59,990,000 +$31,769,000 +113% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 $60,426,000 +$32,205,000 +114% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $28,221,000 $0 0% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $28,221,000 $0 0% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $28,221,000 $0 0% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $28,221,000 $0 0% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $28,221,000 $0 0% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $28,221,000 +$33,000 +0.12% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $28,221,000 +$333,000 +1.2% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $28,221,000 +$24,641,000 +688% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $28,221,000 +$24,641,000 +688% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $28,188,000 +$24,608,000 +687% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $27,888,000 +$24,308,000 +679% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $3,580,000 $0 0% 30 Sep 2021 10-Q 01 Nov 2021 2021 Q3
Q2 2021 $3,580,000 $0 0% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $3,580,000 $0 0% 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $3,580,000 $0 0% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $3,580,000 $0 0% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $3,580,000 $0 0% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $3,580,000 $0 0% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $3,580,000 $0 0% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 $3,580,000 -$600,000 -14% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $3,580,000 +$1,742,000 +95% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $3,580,000 +$1,742,000 +95% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $3,580,000 +$1,742,000 +95% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q3 2018 $4,180,000 +$2,342,000 +127% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 $1,838,000 $0 0% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $1,838,000 $0 0% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 $1,838,000 $0 0% 31 Dec 2017 10-K 27 Feb 2020 2019 FY
Q3 2017 $1,838,000 $0 0% 30 Sep 2017 10-Q 02 Nov 2017 2017 Q3
Q2 2017 $1,838,000 $0 0% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 $1,838,000 $0 0% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 $1,838,000 $0 0% 31 Dec 2016 10-K 27 Feb 2019 2018 FY
Q3 2016 $1,838,000 $0 0% 30 Sep 2016 10-Q 03 Nov 2016 2016 Q3
Q2 2016 $1,838,000 $0 0% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $1,838,000 $0 0% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 $1,838,000 $0 0% 31 Dec 2015 10-K 02 Mar 2017 2016 FY
Q3 2015 $1,838,000 $0 0% 30 Sep 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 $1,838,000 $0 0% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 $1,838,000 $0 0% 31 Mar 2015 10-Q 05 May 2015 2015 Q1
Q4 2014 $1,838,000 $0 0% 31 Dec 2014 10-K 23 Feb 2016 2015 FY
Q3 2014 $1,838,000 -$309 -0.02% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 $1,838,000 -$309 -0.02% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $1,838,000 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 $1,838,000 +$1,838,000 31 Dec 2013 10-K 23 Feb 2015 2014 FY
Q3 2013 $1,838,309 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $1,838,309 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q4 2012 $0 31 Dec 2012 10-K 28 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.